02/24/2021 /
Video telemedicine visits are a feasible and effective way to provide care for children and adolescents with psychogenic non-epileptic events.
02/24/2021 /
Information obtained as part of routine clinical care can be collected in a prospective, standardized, efficient manner and be used to construct filterable, process/outcomes dashboards, updated in near time (36 hours).
02/23/2021 /
Adherence of known people with epilepsy to anti-seizure medication treatment appeared to remain stable during lockdown in Germany. However, this study revealed findings which point to reduced care for newly diagnosed PWE.
02/22/2021 /
From a developmental perspective, corpus callosotomy for drug-resistant epilepsy in early childhood is an effective treatment.
02/19/2021 /
Ultra-high definition predictive brain tool seeks to give surgeons a sharp eye to spot epilepsy in a patient’s brain.
02/19/2021 /
They showed in mice that low-frequency stimulation of specific brain areas could completely stop epileptic activity. Instead of using electric current, the researchers stimulated the cells with light.
02/19/2021 /
CURE Epilepsy has signed on to a letter from a coalition led by the Tuberous Sclerosis Alliance that asks the National Governors Association to prioritize people with rare diseases, including rare epilepsies, and their caregivers for COVID-19 vaccine distribution.
02/18/2021 /
CURE Epilepsy urges everyone to contact their respective representatives and senators to recommend passage of The RISE Act (H.R.869, S.289).
02/18/2021 /
Patients with epilepsy are not susceptible to contracting COVID?19 more than other individuals. Furthermore, COVID?19 in PWE is not associated with a more severe illness or a poorer prognosis. However, PWE and COVID?19 may present somewhat differently than others with such an illness.
